Oncology Research
Developing precision gene therapies and immunotherapies to target cellular aberrations, overcome tumour immune evasion, and neutralize tumor progression.
Oncology Research Pillars
Tumour Microenvironment
Overcoming immunosuppressive barriers within the tumour stroma to enable immune infiltration.
Cellular Immunotherapy
Engineered cellular platforms targeting aberrant tumour antigens and metabolic adaptations.
Targeted Vector Delivery
Tumour-selective promoter design and capsid tropism for localized biological activity.
Combination Paradigms
Translational synergies with standard oncology regimens, diagnostics, and immune checkpoints.
Development Logic & Milestones
Target Discovery
Genomic and proteomic target validation in patient-derived cancer models.
Vector Engineering
Optimizing payload potency and promoter specificity for selective expression.
Preclinical Efficacy
In vivo tumour suppression, immune activation, and systemic toxicology.
Translational Study
Patient selection criteria and biomarker-guided clinical trial protocols.
Partner with our oncology translational development team.